Cargando…
Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
BACKGROUND: Leiomyosarcomas represent the largest subtype of soft tissue sarcomas. Two subgroups can be distinguished, non-uterine (NULMS) and uterine leiomyosarcomas (ULMS). The aim of this retrospective study was to evaluate differences in clinical features and outcome between these two subgroups....
Autores principales: | Lamm, Wolfgang, Natter, Camilla, Schur, Sophie, Köstler, Wolfgang J, Reinthaller, Alexander, Krainer, Michael, Grimm, Christoph, Horvath, Reinhard, Amann, Gabriele, Funovics, Philipp, Brodowicz, Thomas, Polterauer, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320583/ https://www.ncbi.nlm.nih.gov/pubmed/25523155 http://dx.doi.org/10.1186/1471-2407-14-981 |
Ejemplares similares
-
The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2015) -
Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016) -
Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study
por: Bekos, Christine, et al.
Publicado: (2017) -
Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
por: Lamm, W., et al.
Publicado: (2010) -
Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)